Yongxing Zhao

No. 100 Science Ave
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

A novel mRNA nanovaccine with dual immunoregulation ameliorates rheumatoid arthritis and associated pneumonia.

A novel mRNA nanovaccine with dual immunoregulation ameliorates rheumatoid arthritis and associated pneumonia.

Journal: Asian journal of pharmaceutical sciences

Published: July 21, 2025

Augmenting Antioxidant Enzyme-Like Activity and Hydrogen Evolution of MoS2@Bi2S3 Heterojunction via Ultrasound-Evoked Piezoelectricity for Anti-Inflammation.

Augmenting Antioxidant Enzyme-Like Activity and Hydrogen Evolution of MoS2@Bi2S3 Heterojunction via Ultrasound-Evoked Piezoelectricity for Anti-Inflammation.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: February 07, 2025

Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification.

Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification.

Journal: Molecules (Basel, Switzerland)

Published: September 25, 2024

Correction: Antimicrobial peptide-modified silver nanoparticles for enhancing the antibacterial efficacy.

Correction: Antimicrobial peptide-modified silver nanoparticles for enhancing the antibacterial efficacy.

Journal: RSC advances

Published: April 10, 2024

Targeted delivery of NO donor and ROS scavenger for synergistic treatment of rheumatoid arthritis.

Targeted delivery of NO donor and ROS scavenger for synergistic treatment of rheumatoid arthritis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 09, 2023

Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases.

Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 09, 2022

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug.

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug.

Journal: International journal of pharmaceutics: X

Published: September 14, 2022

Stimulus-responsive and dual-target DNA nanodrugs for rheumatoid arthritis treatment.

Stimulus-responsive and dual-target DNA nanodrugs for rheumatoid arthritis treatment.

Journal: International journal of pharmaceutics

Published: August 28, 2022

Catalytic DNA-Assisted Mass Production of Arbitrary Single-Stranded DNA.

Catalytic DNA-Assisted Mass Production of Arbitrary Single-Stranded DNA.

Journal: Angewandte Chemie (International ed. in English)

Published: August 16, 2022

PBA functionalized single-atom Fe for efficient therapy of multidrug-resistant bacterial infections.

PBA functionalized single-atom Fe for efficient therapy of multidrug-resistant bacterial infections.

Journal: Colloids and surfaces. B, Biointerfaces

Published: July 07, 2022

Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy.

Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy.

Journal: Pharmaceutics

Published: May 28, 2022

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design.

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design.

Journal: Frontiers in molecular biosciences

Published: May 17, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026